Prot #C-145-03: A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-145) for the Treatment of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

  • Boumber, Yanis (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/23/18 → 2/23/23

Funding

  • Chiltern International, Inc. ((OE) Prot #C-145-03 // (OE) Prot #C-145-03)
  • Iovance Biotherapeutics, Inc. ((OE) Prot #C-145-03 // (OE) Prot #C-145-03)